These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 10391741)

  • 1. Balsalazide and azathiprine or 6-mercaptopurine: evidence for a potentially serious drug interaction.
    Lowry PW; Szumlanski CL; Weinshilboum RM; Sandborn WJ
    Gastroenterology; 1999 Jun; 116(6):1505-6. PubMed ID: 10391741
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety of balsalazide therapy in the treatment of inflammatory bowel disease.
    Baker DE
    Rev Gastroenterol Disord; 2005; 5(3):135-41. PubMed ID: 16127348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leucopenia resulting from a drug interaction between azathioprine or 6-mercaptopurine and mesalamine, sulphasalazine, or balsalazide.
    Lowry PW; Franklin CL; Weaver AL; Szumlanski CL; Mays DC; Loftus EV; Tremaine WJ; Lipsky JJ; Weinshilboum RM; Sandborn WJ
    Gut; 2001 Nov; 49(5):656-64. PubMed ID: 11600468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Balsalazide and azathioprine or 6-mercaptopurine.
    Green JR
    Gastroenterology; 1999 Dec; 117(6):1513-4. PubMed ID: 10610346
    [No Abstract]   [Full Text] [Related]  

  • 5. Balsalazide disodium.
    Am J Health Syst Pharm; 2002 Jan; 59(1):27. PubMed ID: 11813462
    [No Abstract]   [Full Text] [Related]  

  • 6. Interaction of 6-mercaptopurine and azathioprine with 5-aminosalicylic acid agents.
    Present DH
    Gastroenterology; 2000 Jul; 119(1):276. PubMed ID: 10928833
    [No Abstract]   [Full Text] [Related]  

  • 7. [Combination of purine analogues and aminosalicylates in patients with inflammatory bowel disease: why and how?].
    Jomni T; Dray X; Marteau P
    Gastroenterol Clin Biol; 2007; 31(8-9 Pt 1):758-60. PubMed ID: 17925782
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of ulcerative colitis with balsalazide: response to Drs Johnson, Green, and Pruitt.
    Hanauer SB
    Am J Gastroenterol; 2003 Mar; 98(3):697-8. PubMed ID: 12650813
    [No Abstract]   [Full Text] [Related]  

  • 9. Review article: balsalazide therapy in ulcerative colitis.
    Ragunath K; Williams JG
    Aliment Pharmacol Ther; 2001 Oct; 15(10):1549-54. PubMed ID: 11563993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Balsalazide is superior to mesalamine in the time to improvement of signs and symptoms of acute mild-to-moderate ulcerative colitis.
    Pruitt R; Hanson J; Safdi M; Wruble L; Hardi R; Johanson J; Koval G; Riff D; Winston B; Cross A; Doty P; Johnson LK
    Am J Gastroenterol; 2002 Dec; 97(12):3078-86. PubMed ID: 12492193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, double blind, dose-response comparison of balsalazide (6.75 g), balsalazide (2.25 g), and mesalamine (2.4 g) in the treatment of active, mild-to-moderate ulcerative colitis.
    Levine DS; Riff DS; Pruitt R; Wruble L; Koval G; Sales D; Bell JK; Johnson LK
    Am J Gastroenterol; 2002 Jun; 97(6):1398-407. PubMed ID: 12094857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Balsalazide is more effective and better tolerated than mesalamine in the treatment of acute ulcerative colitis. The Abacus Investigator Group.
    Green JR; Lobo AJ; Holdsworth CD; Leicester RJ; Gibson JA; Kerr GD; Hodgson HJ; Parkins KJ; Taylor MD
    Gastroenterology; 1998 Jan; 114(1):15-22. PubMed ID: 9428213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypersensitivity reaction to balsalazide.
    Adhiyaman V; Vaishnavi A; Froese S
    BMJ; 2000 Mar; 320(7235):613. PubMed ID: 10698880
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects and treatment of inflammatory bowel disease during pregnancy.
    Brar H; Einarson A
    Can Fam Physician; 2008 Jul; 54(7):981-3. PubMed ID: 18625819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What are the rules when treatment with 6-MP/AZA is started?
    Korelitz BI
    Inflamm Bowel Dis; 2008 Oct; 14 Suppl 2():S262-3. PubMed ID: 18816727
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug points: Hypersensitivity reaction to balsalazide.
    Adhiyaman V; Vaishnavi A; Froese S
    BMJ; 2001 Sep; 323(7311):489. PubMed ID: 11532843
    [No Abstract]   [Full Text] [Related]  

  • 17. Equimolar doses of balsalazide and mesalamine: are we comparing apples and oranges?
    Farrell RJ; Peppercorn MA
    Am J Gastroenterol; 2002 Jun; 97(6):1283-5. PubMed ID: 12094839
    [No Abstract]   [Full Text] [Related]  

  • 18. Balsalazide: a review of its therapeutic use in mild-to-moderate ulcerative colitis.
    Muijsers RB; Goa KL
    Drugs; 2002; 62(11):1689-705. PubMed ID: 12109930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Azathioprine or 6-mercaptopurine for inflammatory bowel disease: do risks outweigh benefits?
    Su CG; Stein RB; Lewis JD; Lichtenstein GR
    Dig Liver Dis; 2000; 32(6):518-31. PubMed ID: 11057928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral balsalazide (Colazal) for ulcerative colitis.
    Med Lett Drugs Ther; 2001 Jul; 43(1109):62-3. PubMed ID: 11468602
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.